Logo

Neurome Announces Partnership With ImClone Systems

Sep 24, 2004

NEW YORK, Sept. 24, (GenomeWeb News) - Neurome announced today that it has entered into a research agreement with ImClone Systems in which Neurome will apply its proprietary technologies and expertise in quantitative neuropathology to assist ImClone Systems in the discovery of preclinical candidate molecules.

           

Financial terms of the agreement were not disclosed.

 

"We believe ImClone Systems' decision to work with Neurome is an important validation of our discovery stage capabilities and proprietary technologies," said Floyd Bloom, chairman and founding CEO of Neurome.

 

In August, Neurome announced that it plans to buy all the assets owned by Digital Gene Technologies, including its gene-expression assays and gene-expression-analysis platform called TOGA (see story on Aug. 11).

 

Breaking News
The Scan

More Boosters for US

Following US Food and Drug Administration authorization, the Centers for Disease Control and Prevention has endorsed booster doses of the Moderna and Johnson & Johnson SARS-CoV-2 vaccines, the Washington Post writes.

From a Pig

A genetically modified pig kidney was transplanted into a human without triggering an immune response, Reuters reports.

For Privacy's Sake

Wired reports that more US states are passing genetic privacy laws.

Science Paper on How Poaching Drove Evolution in African Elephants

In Science this week: poaching has led to the rapid evolution of tuskless African elephants.